| 000 | 01368 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250516175258.0 | ||
| 264 | 0 | _c20140902 | |
| 008 | 201409s 0 0 eng d | ||
| 022 | _a1545-4304 | ||
| 024 | 7 |
_a10.1146/annurev-pharmtox-011613-135947 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRudolph, Uwe | |
| 245 | 0 | 0 |
_aGABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autism. _h[electronic resource] |
| 260 |
_bAnnual review of pharmacology and toxicology _c2014 |
||
| 300 |
_a483-507 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAutistic Disorder _xtherapy |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 |
_aCognition _xphysiology |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDown Syndrome _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMemory _xphysiology |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aMood Disorders _xtherapy |
| 650 | 0 | 4 |
_aReceptors, GABA-A _xmetabolism |
| 650 | 0 | 4 |
_aSchizophrenia _xtherapy |
| 700 | 1 | _aMöhler, Hanns | |
| 773 | 0 |
_tAnnual review of pharmacology and toxicology _gvol. 54 _gp. 483-507 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1146/annurev-pharmtox-011613-135947 _zAvailable from publisher's website |
| 999 |
_c23202603 _d23202603 |
||